Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels

Alexander Shcheglovitov1, Tatiana Zhelay, Yulia Vitko

  • 1International Center of Molecular Physiology, National Academy of Sciences of Ukraine, Bogomoletz St. 4, Kyiv-24, Ukraine.

Biochemical Pharmacology
|February 16, 2005
PubMed

Insights

Nifedipine (Nif) blocks T-type calcium channels, with Ca(v)3.2 being the most sensitive. The drug

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Nifedipine (Nif), a dihydropyridine (DHP) calcium channel antagonist, is primarily known for its L-type calcium channel specificity.
  • Emerging evidence suggests Nif can also block low voltage-activated (LVA), or T-type, calcium channels.
  • The precise selectivity of Nif across different T-type channel subtypes (Ca(v)3.1, Ca(v)3.2, Ca(v)3.3) and their endogenous counterparts remains undetermined.

Purpose of the Study:

  • To investigate the effects of Nifedipine (Nif) on cloned T-type calcium channel alpha 1 subunits (Ca(v)3.1, Ca(v)3.2, Ca(v)3.3).
  • To determine the potency and mechanism of Nif blockade on endogenous fast and slow LVA currents in thalamic neurons.
  • To elucidate the relative sensitivity of different T-type calcium channel subtypes to Nif.

Main Methods:

  • Functional expression of Ca(v)3.1, Ca(v)3.2, and Ca(v)3.3 alpha 1 subunits in Xenopus oocytes and HEK-293 cells.
  • Electrophysiological recordings of currents induced by cloned T-type channels (I(alpha 1G), I(alpha 1H), I(alpha 1I)).
  • Voltage-clamp analysis of Nif's effects on endogenous fast and slow LVA currents (I(LVA,f), I(LVA,s)) in thalamic neurons.

Main Results:

  • Nifedipine most potently blocked I(alpha 1H) (IC(50)=5 microM), followed by I(alpha 1G) (IC(50)=109 microM) and I(alpha 1I) (IC(50)=243 microM).
  • Nif blockade involved interaction with open and inactivated states of Ca(v)3.1, Ca(v)3.2, and Ca(v)3.3 channels.
  • In thalamic neurons, Nif blocked I(LVA,f) (IC(50)=22 microM, 81% max block) and I(LVA,s) (IC(50)=28 microM, 51% max block).

Conclusions:

  • Ca(v)3.2 is the T-type calcium channel subtype most sensitive to Nifedipine.
  • The quantitative effects of Nifedipine on T-type calcium channels are dependent on the cellular expression system.
  • Ca(v)3.1 and Ca(v)3.3 likely contribute significantly to thalamic I(LVA,f) and I(LVA,s), respectively.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...